QUICK ANSWER · AEO / GEO
An SNRI with product-specific psychiatric and pain indications; two premature-ejaculation RCTs are discussed by EAU, but longer-term evidence is still requested before widespread recommendation.
ENTITY FACTS
What should readers identify first?
What remains unknown?
English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.
Read original excerpts (Thai / mixed language)
- งานทดลอง PE สองงานไม่ทำให้ duloxetine เป็นยาที่อนุมัติสำหรับ PE และไม่เท่ากับคำแนะนำให้ใช้อย่างแพร่หลาย
- Duloxetine เป็น SNRI ไม่ใช่ SSRI และไม่ควรถ่ายโอนหลักฐานหรือความเสี่ยงจาก paroxetine, sertraline, fluoxetine, citalopram หรือ fluvoxamine มาใช้แทน
- ผลต่อการหลั่งไม่ใช่หลักฐานรักษาภาวะหย่อนสมรรถภาพทางเพศ เพิ่มความต้องการ หรือเพิ่มความพึงพอใจในทุกคน
What limits these conclusions?
Insufficient data in the current dataset
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
FAQ · ANSWER ENGINE
Frequently asked questions
What is Duloxetine?
Duloxetine is described pharmacologically as Serotonin and norepinephrine reuptake inhibitor (SNRI). An SNRI with product-specific psychiatric and pain indications; two premature-ejaculation RCTs are discussed by EAU, but longer-term evidence is still requested before widespread recommendation.
Does Duloxetine have strong evidence?
PrimeCoreBio records Evidence Grade B. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is Duloxetine approved everywhere?
No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.